Murray Stewart, T., Von Hoff, D., Fitzgerald, M., Marton, L. J., Becerra, C. H. R., Boyd, T. E., . . . Casero, R. A. (2020). A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma. Cancer Chemother Pharmacol.
Citação norma ChicagoMurray Stewart, Tracy, et al. "A Phase Ib Multicenter, Dose-escalation Study of the Polyamine Analogue PG-11047 in Combination With Gemcitabine, Docetaxel, Bevacizumab, Erlotinib, Cisplatin, 5-fluorouracil, or Sunitinib in Patients With Advanced Solid Tumors or Lymphoma." Cancer Chemother Pharmacol 2020.
Citação norma MLAMurray Stewart, Tracy, et al. "A Phase Ib Multicenter, Dose-escalation Study of the Polyamine Analogue PG-11047 in Combination With Gemcitabine, Docetaxel, Bevacizumab, Erlotinib, Cisplatin, 5-fluorouracil, or Sunitinib in Patients With Advanced Solid Tumors or Lymphoma." Cancer Chemother Pharmacol 2020.